Buy PLAYQUIN-H 400mg Tablet 20s Online At Best Price In Pakistan

Dosage

Missed Dose

Take the missed dose as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions

Thioridazine   (severe)

Aluminium Hydroxide/Magnesium Hydroxide   (moderate)

Antidiabetic medicines   (moderate)

Atorvastatin   (moderate)

Prescribes

Rheumatoid Arthritis

This medicine is used for the treatment of rheumatoid arthritis, an autoimmune disease that affects the smaller joints in the body and causes pain and swelling.

Systemic Lupus Erythematosus

This medicine is used for the treatment of systemic lupus erythematosus (SLE), an autoimmune disease where the immune system attacks its healthy tissue.

Malaria

This medicine is used for the treatment of malaria characterized by muscle pain, fever with chills and fatigue.

Malaria prophylaxis

This medicine is used as a prophylactic treatment for malaria in individuals who are traveling to malaria-prone countries and those who are living in malaria areas having little or no immunity to malaria.

Coronavirus Disease (COVID-19)

The FDA has issued an unapproved use of this medicine for the treatment of patients with mild, moderate, and severe COVID-19 caused by the new coronavirus. Use this medicine to treat COVID-19 only when the doctor recommends.

Side Effects

Blurred vision  

Muscle weakness   (rare)

Ringing or buzzing in the ears   (rare)

Sore throat   (rare)

Diarrhea  

Headache  

Loss of appetite  

Nausea and Vomiting  

Skin rash  

Nervousness  

Dizziness  

Warnings

Heart diseases

Musculoskeletal effects

Kidney diseases

Liver diseases

Hearing problem

Driving or operating machinery

Coronavirus Disease COVID-19

Pregnancy

Breast-feeding

When Not To Use

Allergy

This medicine is not recommended for use in patients with a known allergy to PLAYQUIN-H 400mg Tablet 20s , 4-aminoquinolones, or any other inactive ingredients present in the formulation.

Retinal or visual field changes

This medicine is not recommended for use in patients with any vision impairment due to the risk of worsening of the patient's condition.